Predicting HIV-1 broadly neutralizing antibody epitope networks using neutralization titers and a novel computational method

BackgroundRecent efforts in HIV-1 vaccine design have focused on immunogens that evoke potent neutralizing antibody responses to a broad spectrum of viruses circulating worldwide. However, the development of effective vaccines will depend on the identification and characterization of the neutralizing antibodies and their epitopes. We developed bioinformatics methods to predict epitope networks and antigenic determinants using structural information, as well as corresponding genotypes and phenotypes generated by a highly sensitive and reproducible neutralization assay.282 clonal envelope sequences from a multiclade panel of HIV-1 viruses were tested in viral neutralization assays with an array of broadly neutralizing monoclonal antibodies (mAbs: b12, PG9,16, PGT121 - 128, PGT130 - 131, PGT135 - 137, PGT141 - 145, and PGV04). We correlated IC50 titers with the envelope sequences, and used this information to predict antibody epitope networks. Structural patches were defined as amino acid groups based on solvent-accessibility, radius, atomic depth, and interaction networks within 3D envelope models. We applied a boosted algorithm consisting of multiple machine-learning and statistical models to evaluate these patches as possible antibody epitope regions, evidenced by strong correlations with the neutralization response for each antibody.ResultsWe identified patch clusters with significant correlation to IC50 titers as sites that impact neutralization sensitivity and therefore are potentially part of the antibody binding sites. Predicted epitope networks were mostly located within the variable loops of the envelope glycoprotein (gp120), particularly in V1/V2. Site-directed mutagenesis experiments involving residues identified as epitope networks across multiple mAbs confirmed association of these residues with loss or gain of neutralization sensitivity.ConclusionsComputational methods were implemented to rapidly survey protein structures and predict epitope networks associated with response to individual monoclonal antibodies, which resulted in the identification and deeper understanding of immunological hotspots targeted by broadly neutralizing HIV-1 antibodies.

[1]  Violaine Moreau,et al.  Discontinuous epitope prediction based on mimotope analysis , 2006, Bioinform..

[2]  Jamie K. Scott,et al.  Structure of a high-affinity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies. , 2007, Journal of molecular biology.

[3]  Pham Phung,et al.  Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target , 2009, Science.

[4]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[5]  B. Lee,et al.  The interpretation of protein structures: estimation of static accessibility. , 1971, Journal of molecular biology.

[6]  Yang Lu,et al.  MimoPro: a more efficient Web-based tool for epitope prediction using phage display libraries , 2011, BMC Bioinformatics.

[7]  Lynn Morris,et al.  Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? , 2009, Nature Medicine.

[8]  Ross Ihaka,et al.  Gentleman R: R: A language for data analysis and graphics , 1996 .

[9]  Martin A. Nowak,et al.  Antibody neutralization and escape by HIV-1 , 2003, Nature.

[10]  Mario Roederer,et al.  Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 , 2010, Science.

[11]  Ryan McBride,et al.  Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans , 2013, PLoS pathogens.

[12]  Ming Li,et al.  Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies , 2010, PLoS Comput. Biol..

[13]  Oliviero Carugo,et al.  Atom depth as a descriptor of the protein interior. , 2003, Biophysical journal.

[14]  Baoshan Zhang,et al.  Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16 , 2013, Nature Structural &Molecular Biology.

[15]  Jinyan Li,et al.  Mining for the antibody-antigen interacting associations that predict the B cell epitopes , 2010, BMC Structural Biology.

[16]  Kurt Hornik,et al.  Misc Functions of the Department of Statistics (e1071), TU Wien , 2014 .

[17]  Alf Merriweather,et al.  Monogram Biosciences, Inc. , 2005, Personalized medicine.

[18]  Tongqing Zhou,et al.  PGV04, an HIV-1 gp120 CD4 Binding Site Antibody, Is Broad and Potent in Neutralization but Does Not Induce Conformational Changes Characteristic of CD4 , 2012, Journal of Virology.

[19]  Hiroki Shirai,et al.  Use of amino acid composition to predict epitope residues of individual antibodies. , 2010, Protein engineering, design & selection : PEDS.

[20]  Renate Kunert,et al.  Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies , 2004, Journal of Virology.

[21]  Itay Mayrose,et al.  Stepwise prediction of conformational discontinuous B‐cell epitopes using the Mapitope algorithm , 2007, Proteins.

[22]  B. Walker,et al.  Immunology and the elusive AIDS vaccine , 2010, Nature.

[23]  김삼묘,et al.  “Bioinformatics” 특집을 내면서 , 2000 .

[24]  Nimrod D. Rubinstein,et al.  Epitope mapping using combinatorial phage-display libraries: a graph-based algorithm , 2006, Nucleic acids research.

[25]  Mark C Evans,et al.  Recent advances in immunoinformatics: application of in silico tools to drug development. , 2008, Current opinion in drug discovery & development.

[26]  Susan Jones,et al.  SHARP2: protein-protein interaction predictions using patch analysis , 2006, Bioinform..

[27]  Vasant Honavar,et al.  Recent advances in B-cell epitope prediction methods , 2010, Immunome research.

[28]  BMC Bioinformatics , 2005 .

[29]  M. V. Van Regenmortel,et al.  Basic research in HIV vaccinology is hampered by reductionist thinking , 2012, Front. Immun..

[30]  D Sydman,et al.  Placebocontrolled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 InfectionGurwith M, for the rgp 120 HIV Vaccine Study Group (VaxGen, Brisbane, Calif; et al) J Infect Dis 191:654–665, 2005§ , 2006 .

[31]  S. Jones,et al.  Prediction of protein-protein interaction sites using patch analysis. , 1997, Journal of molecular biology.

[32]  M. Levitt,et al.  Conformation of amino acid side-chains in proteins. , 1978, Journal of molecular biology.

[33]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[34]  Pham Phung,et al.  Broad neutralization coverage of HIV by multiple highly potent antibodies , 2011, Nature.

[35]  Nadezhda T. Doncheva,et al.  Analyzing and visualizing residue networks of protein structures. , 2011, Trends in biochemical sciences.

[36]  Gerald R. Nakamura,et al.  Monoclonal Antibodies to the V2 Domain of MN-rgp120: Fine Mapping of Epitopes and Inhibition of α4β7 Binding , 2012, PloS one.

[37]  Shandar Ahmad,et al.  Context dependent reference states of solvent accessibility derived from native protein structures and assessed by predictability analysis , 2015 .

[38]  Young Do Kwon,et al.  Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 , 2011, Nature.

[39]  Punnee Pitisuttithum,et al.  Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. , 2006, The Journal of infectious diseases.

[40]  Di Wu,et al.  SEPPA: a computational server for spatial epitope prediction of protein antigens , 2009, Nucleic Acids Res..

[41]  Paul W. H. I. Parren,et al.  Fine Mapping of the Interaction of Neutralizing and Nonneutralizing Monoclonal Antibodies with the CD4 Binding Site of Human Immunodeficiency Virus Type 1 gp120 , 2003, Journal of Virology.

[42]  Baoshan Zhang,et al.  Crystal Structure of Human Antibody 2909 Reveals Conserved Features of Quaternary Structure-Specific Antibodies That Potently Neutralize HIV-1 , 2010, Journal of Virology.

[43]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[44]  Morten Nielsen,et al.  CPHmodels-3.0—remote homology modeling using structure-guided sequence profiles , 2010, Nucleic Acids Res..

[45]  Damien C Tully,et al.  A study of the coevolutionary patterns operating within the env gene of the HIV-1 group M subtypes. , 2007, Molecular biology and evolution.

[46]  S. Eddy.  Hidden Markov models. , 1996, Current opinion in structural biology.

[47]  Rong Liu,et al.  Prediction of Discontinuous B-Cell Epitopes Using Logistic Regression and Structural Information , 2011 .

[48]  David Nemazee,et al.  Rational immunogen design to target specific germline B cell receptors , 2012, Retrovirology.

[49]  Dennis R Burton,et al.  A Boost for HIV Vaccine Design , 2010, Science.

[50]  Terri Wrin,et al.  Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm , 2009, Journal of Virology.

[51]  D. Richman,et al.  Rapid evolution of the neutralizing antibody response to HIV type 1 infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Kenneth H Mayer,et al.  Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. , 2005, The Journal of infectious diseases.

[53]  C. Chothia.  The nature of the accessible and buried surfaces in proteins. , 1976, Journal of molecular biology.

[54]  Geoffrey I. Webb,et al.  Prodepth: Predict Residue Depth by Support Vector Regression Approach from Protein Sequences Only , 2009, PloS one.

[55]  Robyn L Stanfield,et al.  Antibody vs. HIV in a clash of evolutionary titans. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Nimrod D. Rubinstein,et al.  A machine-learning approach for predicting B-cell epitopes. , 2009, Molecular immunology.

[57]  Meng Zhao,et al.  Prediction of conformational B-cell epitopes from 3D structures by random forests with a distance-based feature , 2011, BMC Bioinformatics.

[58]  Gil Amitai,et al.  Network analysis of protein structures identifies functional residues. , 2004, Journal of molecular biology.

[59]  Laurent Tran,et al.  Evidence for a Continuous Drift of the HIV-1 Species towards Higher Resistance to Neutralizing Antibodies over the Course of the Epidemic , 2013, PLoS pathogens.